ON DEMAND

Online education and training provided through programs, modules, and presentations

The Latest

In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the over utilization of IgM serologic testing for Herpes Simplex virus and the recommendation by multiple agencies, including the CDC and the Infectious Diseases Society of America, to avoid using this test for clinical decision making purposes. As a result of these recommendations and data generated at Mayo Clinic, Dr. Theel will summarize why HSV IgM testing will no longer be offered through Mayo Clinic Laboratories.
By MCL Education • November 11, 2019
PACE / State of CA / State of FL
This "Phlebotomy webinar" will discuss ethical issues frequently faced by phlebotomists.
By MCL Education • November 6, 2019
In this month’s “Hot Topic,” Paul Jannetto, Ph.D. discusses the proper procedures for collecting and processing kidney stones in order to provide accurate, cost-effective analysis of patients’ kidney stones in a timely manner.
By MCL Education • November 4, 2019
PACE / State of CA / State of FL
In this month’s “Virtual Lecture,” Melissa Snyder, Ph.D., shares information on therapeutic monoclonal antibodies, therapeutic MAb quantitation, and their immunogenicity assessment.
By MCL Education • October 23, 2019
In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.
By MCL Education • October 21, 2019
In this month’s “Hot Topic,” Jessie Swanson and Michelle Soland from the Component Laboratory will discuss the process improvement that helped decrease the standard cryoprecipitate dosage and the positive impact it has on patients.
By MCL Education • October 7, 2019
PACE / State of CA / State of FL
In this month’s “Virtual Lecture” Stephen Boorjian, M.D., and Loren Herrera Hernandez, M.D., will discuss significant information regarding bladder cancer.
By MCL Education • September 26, 2019
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections.
By MCL Education • September 9, 2019